Implementation of guidelines on oxytocin use at caesarean section: A survey of practice in Great Britain and Ireland

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 148, Issue 2, 2010, Pages 121-124

  Sheehan, Sharon R ^a   Wedisinghe, Lilantha ^b   Macleod, Maureen ^b   Murphy, Deirdre J ^a  

^a Pathology Research Laboratory   (Ireland)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Blood loss; Guideline implementation; Oxytocin: caesarean section; Survey

Indexed keywords

OXYTOCIN;

ANESTHESIOLOGY; ARTICLE; BLEEDING; BOLUS INJECTION; CESAREAN SECTION; CONSULTATION; GYNECOLOGY; HUMAN; IRELAND; LABOR; MAJOR CLINICAL STUDY; MEASUREMENT; OBSTETRICS; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; QUESTIONNAIRE; RESPONSIBILITY; UNITED KINGDOM; WARD;

EID: 73749084801     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.10.004     Document Type: Article

References (19)

1. Martin J.A., Hamilton B.E., Ventura S.J., Mnacker F., Park M.M., and Sutton P.D. Births: final data for 2001 (2002), National Centre for Health Statistics, Division of Vital Statistics, Hyattsville p. 1
2. Thomas J, Paranjothy S, Royal College of Obstetricians and Gynaecologists Clinical Effectiveness Support Unit. National Sentinel Caesarean Section Audit Report. 2RCOG Press; 2001.
3. Cai W.W., Marks J.S., Chen C.H., Zhuang Y.X., Morris L., and Harris J.R. Increased caesarean section rates and emerging patterns of health insurance in Shanghai, China. Am J Pub Health 88 (1998) 777-780
4. Births in Scotland report (Births 1981-2000) Information and Statistics Division; 2002. www.show.scot.nhs.uk/isd/sexual_health.
5. Elbourne D.R., Prendiville W.J., Carroli G., Wood J., and McDonald S. Prophylactic use of oxytocin in the third stage of labour (Cochrane Review) vol. 1 (2004), John Wiley & Sons, Ltd., Chichester, UK [the Cochrane Library]
6. Bolton T.J., Randall K., and Yentis S.M. Effect of the confidential enquiries into maternal deaths on the syntocinon at caesarean section in the UK. Anaesthesia 58 (2003) 277-279
7. Khan M.M., Gupta S., Radford P., and Male D.A. Dose of oxytocin after caesarean section. Anaesthesia 57 (2002) 723-724
8. Wedisinghe L., Macleod M., and Murphy D.J. Use of oxytocin to prevent haemorrhage at caesarean section-a survey of practice in the United Kingdom. Eur J Obstet Gynecol Reprod Biol 137 (2008) 27-30
9. Caesarean Section. Clinical guideline. National Collaborating Centre for Women's and Children's Health (2004), RCOG Press, London
10. Anderson J., Etches D., and Smith D. Postpartum haemorrhage. In: Damos J.R., and Eisinger S.H. (Eds). Advanced life support in obstetrics (ALSO) provider course manual (2000), American Academy of Family Physicians, Kansas pp. J1-15
11. Murphy D.J., MacGregor H., Munishankar B., and McLeod G. A randomised controlled trial of oxytocin 5 IU and placebo infusion versus oxytocin 5 IU and 30 IU infusion for the control of blood loss at elective caesarean section-Pilot study. ISRCTN40302163. Eur J Obstet Gynecol Reprod Biol 142 (2009) 30-33
12. Bolton T.J., Randall K., and Yentis S.M. Effect of the confidential enquiries into maternal deaths on the use of syntocinon at caesarean section in the UK. Anaesthesia 58 (2003) 277-279
13. Carvalho J.C., Balki M., Kingdom J., and Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol 104 (2004) 1005-1010
14. Balki M., Ronayne M., Davies S., et al. Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol 107 (2006) 45-50
15. Lombaard H., and Pattinson R.C. Common errors and remedies in managing postpartum haemorrhage. Best Prac Res Clin Obstet Gynaecol 23 (2009) 317-326
16. Lesar T.S., Briceland L., and Stein D.S. Factors related to errors in medication prescribing. JAMA 277 (1997) 312-317
17. Murphy J.F. The Lourdes Hospital inquiry: its implications for medical practice. Ir Med J 99 March (3) (2006) 68-69
18. Bose P., Regan F., and Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 113 (2006) 919-924
19. Murphy D.J., Carey M., Montgomery A.A., Sheehan S.R., and ECSSIT Study Group. Study Protocol. ECSSIT-Elective Caesarean Section Syntocinon Infusion Trial. A multi-centre randomised controlled trial of oxytocin (Syntocinon) 5 IU bolus and placebo infusion versus oxytocin 5 IU bolus and 40 IU infusion for the control of blood loss at elective caesarean section. BMC Pregnancy Childbirth 9 (2009) 36